Live from the NIH registry
Studies recruiting near Fort Worth right now
Top 25 of 639 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Fort Worth, Texas (4.2 mi)
· Sponsor: Medtronic
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Arlington Nephrology — Arlington, Texas (14.3 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
Cytomegalovirus (CMV)
Phase 3
Interventional 80 participants sought
Cook Children's Health Care System — Fort Worth, Texas (4.2 mi)
· Sponsor: Takeda
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Texas Oncology-Fort Worth Cancer Center — Fort Worth, Texas (4.2 mi)
· Sponsor: Kartos Therapeutics, Inc.
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10301, Fort Worth, TX — Fort Worth, Texas (4.2 mi)
· Sponsor: Colorado Prevention Center
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
JPS Health Network — Fort Worth, Texas (4.2 mi)
· Sponsor: Hoffmann-La Roche
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
University of Texas Southwestern Medical Center — Fort Worth, Texas (4.2 mi)
· Sponsor: Lyell Immunopharma, Inc.
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
GI Alliance Southlake — Southlake, Texas (16.6 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
Muscular Atrophy, Spinal
Phase 3
Interventional 30 participants sought
Neurology Rare Disease Center — Flower Mound, Texas (21.7 mi)
· Sponsor: Biogen
A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)
Ovarian Cancer, Peritoneal Cancer
Phase 3
Interventional 646 participants sought
JPS Oncology and Infusion Center ( Site 0019) — Fort Worth, Texas (4.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
UT Southwestern/Simmons Cancer Center-Fort Worth — Fort Worth, Texas (4.2 mi)
· Sponsor: NRG Oncology
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Infant, Extremely Premature, Obstetric Labor, Premature
N/A
Observational 5,000 participants sought
Texas Health Resources Harris Hospital — Fort Worth, Texas (4.2 mi)
· Sponsor: The University of Texas Health Science Center, Houston
Targeting Endoplasmic Reticulum Stress in Human Hypertension
Hypertension
Phase 1, Phase 2
Interventional 70 participants sought
University of North Texas Health Science Center — Fort Worth, Texas (4.2 mi)
· Sponsor: University of North Texas Health Science Center
WRAP North America
Venous Stenosis, Venous Occlusion
N/A
Observational 250 participants sought
Texas Research Institute — Fort Worth, Texas (4.2 mi)
· Sponsor: Merit Medical Systems, Inc.
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
Texas Oncology - DFW ( Site 8004) — Fort Worth, Texas (4.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Texas Oncology-Northeast Texas — Flower Mound, Texas (21.7 mi)
· Sponsor: Pfizer
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Phase 2
Interventional 105 participants sought
Enveda Investigative Site — Arlington, Texas (14.3 mi)
· Sponsor: Enveda Therapeutics
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Locally Advanced Cervical Cancer
Phase 3
Interventional 800 participants sought
Research Site — Fort Worth, Texas (4.2 mi)
· Sponsor: AstraZeneca
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
UT Southwestern/Simmons Cancer Center-Fort Worth — Fort Worth, Texas (4.2 mi)
· Sponsor: NRG Oncology
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Helios Clinical Research - WEA — Weatherford, Texas (26.2 mi)
· Sponsor: Pfizer
Pelacarsen Roll-over Extension Program
Atherosclerotic Cardiovascular Disease
Phase 3
Interventional 599 participants sought
North Hills Medical Research Inc — Bedford, Texas (12.6 mi)
· Sponsor: Novartis Pharmaceuticals
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
JPS Oncology and Infusion Center ( Site 0083) — Fort Worth, Texas (4.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
University of Texas Southwestern Simmons Cancer Center - Fort Worth — Fort Worth, Texas (4.2 mi)
· Sponsor: Pfizer
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 150 participants sought
Re:Cognition Health - Fort Worth — Fort Worth, Texas (4.2 mi)
· Sponsor: Eli Lilly and Company
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
North Hills Medical Research Inc. (North Hills Family Medicine) — North Richland Hills, Texas (7.8 mi)
· Sponsor: Ardelyx